Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects

被引：0
|
作者：
Karlsson, P [1 ]
Dencker, E [1 ]
Nyberg, S [1 ]
Mannaert, E [1 ]
Boom, S [1 ]
Talluri, K [1 ]
Rossenu, S [1 ]
Eriksson, B [1 ]
Eerdekens, M [1 ]
Farde, L [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Beerse, Belgium
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S386 / S386
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Cselenyi, Z
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 85 - 86
  • [2] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects:: Two open-label, single-dose studies.
    Karlsson, P
    Dencker, E
    Nyberg, S
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P74 - P74
  • [3] Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115)
    Karlsson, P.
    Hargarter, L.
    Dencker, E.
    Nyberg, S.
    Mannaert, E.
    Boom, S.
    Talluri, K.
    Rossenu, S.
    Eriksson, B.
    Eerdekens, M.
    Farde, L.
    PHARMACOPSYCHIATRY, 2007, 40 (05) : 227 - 227
  • [4] Pharmacokinetic-Pharmacodynamic Modeling of the D2 and 5-HT2A Receptor Occupancy of Risperidone and Paliperidone in Rats
    Kozielska, Magdalena
    Johnson, Martin
    Reddy, Venkatesh Pilla
    Vermeulen, An
    Li, Cheryl
    Grimwood, Sarah
    de Greef, Rik
    Groothuis, Geny M. M.
    Danhof, Meindert
    Proost, Johannes H.
    PHARMACEUTICAL RESEARCH, 2012, 29 (07) : 1932 - 1948
  • [5] Pharmacokinetic-Pharmacodynamic Modeling of the D2 and 5-HT2A Receptor Occupancy of Risperidone and Paliperidone in Rats
    Magdalena Kozielska
    Martin Johnson
    Venkatesh Pilla Reddy
    An Vermeulen
    Cheryl Li
    Sarah Grimwood
    Rik de Greef
    Geny M. M. Groothuis
    Meindert Danhof
    Johannes H. Proost
    Pharmaceutical Research, 2012, 29 : 1932 - 1948
  • [6] A PET Study of 5-HT2 and D2 Dopamine Receptor Occupancy Induced by Olanzapine in Healthy Subjects
    Svante Nyberg
    Lars Farde
    Christer Halldin
    Neuropsychopharmacology, 1997, 16 : 1 - 7
  • [7] Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy men
    B. Andrée
    Christer Halldin
    Maria Vrijmoed-de Vries
    Lars Farde
    Psychopharmacology, 1997, 131 : 339 - 345
  • [8] A positron emission tomography (pet) study of cerebral dopamine D2 and serotonin 5-HT2A receptor occupancy of cyamemazine (Tercian®)
    Hode, Y
    Baylé, FJ
    Nuss, P
    Demazières, A
    Luthringer, R
    Reimold, M
    Hameg, A
    Dib, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S258 - S258
  • [9] Paliperidone -: Antipsychotic agent, treatment of bipolar disorder, dual dopamine D2/5-HT2A receptor antagonist
    Revill, P.
    Serradell, N.
    Bolos, J.
    DRUGS OF THE FUTURE, 2006, 31 (07) : 579 - 584
  • [10] Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
    Albizu, Laura
    Holloway, Terrell
    Gonzalez-Maeso, Javier
    Sealfon, Stuart C.
    NEUROPHARMACOLOGY, 2011, 61 (04) : 770 - 777
12345